Guardant Health Company
Diagnostics company founded in 2012 in Redwood City, California. Guardant develops liquid biopsy tests for cancer detection and monitoring, analyzing circulating tumor DNA (ctDNA). Its flagship products include Guardant360® for advanced cancer profiling and Shield™ for early detection. Guardant partners with pharma for trial support and with healthcare systems for clinical adoption. (guardanthealth.com)
Headquarters:
3100 Hanover Street, Palo Alto, CA 94304
Employee Number:
1500
Estimated Revenue:
$739.0M (FY2024)
Founded Date:
2012